- MeSH
- diabetes mellitus 2. typu epidemiologie komplikace prevence a kontrola MeSH
- kardiovaskulární nemoci epidemiologie komplikace prevence a kontrola MeSH
- kongresy jako téma MeSH
- lidé MeSH
- metabolické nemoci epidemiologie prevence a kontrola MeSH
- náklady na zdravotní péči statistika a číselné údaje MeSH
- praktické lékařství * organizace a řízení trendy MeSH
- primární zdravotní péče * metody MeSH
- screeningové diagnostické programy MeSH
- zdravotní výchova metody MeSH
- Check Tag
- lidé MeSH
- MeSH
- antidepresiva škodlivé účinky MeSH
- antipsychotika škodlivé účinky MeSH
- diabetes mellitus 2. typu chemicky indukované komplikace MeSH
- kyselina valproová aplikace a dávkování škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- metabolické nemoci * chemicky indukované patofyziologie prevence a kontrola MeSH
- nevhodné předepisování MeSH
- obezita chemicky indukované komplikace MeSH
- paranoidní schizofrenie * farmakoterapie MeSH
- rizikové faktory kardiovaskulárních chorob MeSH
- tělesná hmotnost účinky léků MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- kazuistiky MeSH
- MeSH
- adrenoleukodystrofie diagnóza genetika MeSH
- dítě MeSH
- lidé MeSH
- lyzozomální nemoci z ukládání klasifikace patofyziologie MeSH
- metabolické nemoci * diagnóza klasifikace prevence a kontrola MeSH
- minerály klasifikace metabolismus MeSH
- mitochondriální nemoci diagnóza klasifikace metabolismus patofyziologie MeSH
- neurodegenerativní nemoci * diagnóza klasifikace klasifikace MeSH
- neuronální ceroidlipofuscinózy diagnóza MeSH
- sfingolipidózy diagnóza klasifikace MeSH
- vitaminy klasifikace metabolismus MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- přehledy MeSH
To update the European Association for the Study of Diabetes clinical practice guidelines for nutrition therapy, we conducted an umbrella review and updated systematic review and meta-analysis (SRMA) of prospective cohort studies of the association between dietary pulses with or without other legumes and cardiometabolic disease outcomes. We searched the PubMed, MEDLINE, EMBASE, and Cochrane databases through March 2019. We included the most recent SRMAs of prospective cohort studies and new prospective cohort studies published after the census dates of the included SRMAs assessing the relation between dietary pulses with or without other legumes and incidence and mortality of cardiovascular diseases (CVDs) [including coronary heart disease (CHD), myocardial infarction (MI), and stroke], diabetes, hypertension, and/or obesity. Two independent reviewers extracted data and assessed risk of bias. Risk estimates were pooled using the generic inverse variance method and expressed as risk ratios (RRs) with 95% CIs. The overall certainty of the evidence was assessed using the GRADE approach. Six SRMAs were identified and updated to include 28 unique prospective cohort studies with the following number of cases for each outcome: CVD incidence, 10,261; CVD mortality, 16,168; CHD incidence, 7786; CHD mortality, 3331; MI incidence, 2585; stroke incidence, 8570; stroke mortality, 2384; diabetes incidence, 10,457; hypertension incidence, 83,284; obesity incidence, 8125. Comparing the highest with the lowest level of intake, dietary pulses with or without other legumes were associated with significant decreases in CVD (RR: 0.92; 95% CI: 0.85, 0.99), CHD (RR: 0.90; 95% CI: 0.83, 0.99), hypertension (RR: 0.91; 95% CI: 0.86, 0.97), and obesity (RR: 0.87; 95% CI: 0.81, 0.94) incidence. There was no association with MI, stroke, and diabetes incidence or CVD, CHD, and stroke mortality. The overall certainty of the evidence was graded as "low" for CVD incidence and "very low" for all other outcomes. Current evidence shows that dietary pulses with or without other legumes are associated with reduced CVD incidence with low certainty and reduced CHD, hypertension, and obesity incidence with very low certainty. More research is needed to improve our estimates. This trial was registered at clinicaltrials.gov as NCT03555734.
- MeSH
- cévní mozková příhoda epidemiologie prevence a kontrola MeSH
- diabetes mellitus epidemiologie prevence a kontrola MeSH
- dieta * MeSH
- Fabaceae * MeSH
- hypertenze epidemiologie prevence a kontrola MeSH
- infarkt myokardu epidemiologie prevence a kontrola MeSH
- kardiovaskulární nemoci epidemiologie prevence a kontrola MeSH
- koronární nemoc epidemiologie prevence a kontrola MeSH
- lidé MeSH
- metabolické nemoci epidemiologie prevence a kontrola MeSH
- obezita epidemiologie prevence a kontrola MeSH
- prospektivní studie MeSH
- semena rostlinná * MeSH
- stravovací zvyklosti * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
- systematický přehled MeSH
The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD) conducted a review of existing systematic reviews and meta-analyses to explain the relationship between different dietary patterns and patient-important cardiometabolic outcomes. To update the clinical practice guidelines for nutrition therapy in the prevention and management of diabetes, we summarize the evidence from these evidence syntheses for the Mediterranean, Dietary Approaches to Stop Hypertension (DASH), Portfolio, Nordic, liquid meal replacement, and vegetarian dietary patterns. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to assess the quality of evidence. We summarized the evidence for disease incidence outcomes and risk factor outcomes using risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs), respectively. The Mediterranean diet showed a cardiovascular disease (CVD) incidence (RR: 0.62; 95%CI, 0.50, 0.78), and non-significant CVD mortality (RR: 0.67; 95%CI, 0.45, 1.00) benefit. The DASH dietary pattern improved cardiometabolic risk factors (P < 0.05) and was associated with the decreased incidence of CVD (RR, 0.80; 95%CI, 0.76, 0.85). Vegetarian dietary patterns were associated with improved cardiometabolic risk factors (P < 0.05) and the reduced incidence (0.72; 95%CI: 0.61, 0.85) and mortality (RR, 0.78; 95%CI, 0.69, 0.88) of coronary heart disease. The Portfolio dietary pattern improved cardiometabolic risk factors and reduced estimated 10-year coronary heart disease (CHD) risk by 13% (-1.34% (95%CI, -2.19 to -0.49)). The Nordic dietary pattern was correlated with decreased CVD (0.93 (95%CI, 0.88, 0.99)) and stroke incidence (0.87 (95%CI, 0.77, 0.97)) and, along with liquid meal replacements, improved cardiometabolic risk factors (P < 0.05). The evidence was assessed as low to moderate certainty for most dietary patterns and outcome pairs. Current evidence suggests that the Mediterranean, DASH, Portfolio, Nordic, liquid meal replacement and vegetarian dietary patterns have cardiometabolic advantages in populations inclusive of diabetes.
- MeSH
- DASH dieta MeSH
- diabetes mellitus dietoterapie MeSH
- dieta vegetariánská MeSH
- dieta * MeSH
- kardiovaskulární nemoci epidemiologie mortalita prevence a kontrola MeSH
- komplikace diabetu epidemiologie prevence a kontrola MeSH
- lidé MeSH
- MEDLINE MeSH
- metaanalýza jako téma MeSH
- metabolické nemoci epidemiologie prevence a kontrola MeSH
- nutriční terapie metody MeSH
- rizikové faktory MeSH
- strava středomořská MeSH
- systematický přehled jako téma MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Skandinávie a severské státy MeSH
Background: Selective prevention of cardiometabolic diseases (CMD)-that is, preventive measures specifically targeting the high-risk population-may represent the most effective approach for mitigating rising CMD rates. Objectives: To develop a universal concept of selective CMD prevention that can guide implementation within European primary care. Methods: Initially, 32 statements covering different aspects of selective CMD prevention programmes were identified based on a synthesis of evidence from two systematic literature reviews and surveys conducted within the SPIMEU project. The Rand/UCLA appropriateness method (RAM) was used to find consensus on these statements among an international panel consisting of 14 experts. Before the consensus meeting, statements were rated by the experts in a first round. In the next step, during a face-to-face meeting, experts were provided with the results of the first rating and were then invited to discuss and rescore the statements in a second round. Results: In the outcome of the RAM procedure, 28 of 31 statements were considered appropriate and three were rated uncertain. The panel deleted one statement. Selective CMD prevention was considered an effective approach for preventing CMD and a proactive approach was regarded as more effective compared to case-finding alone. The most efficient method to implement selective CMD prevention systematically in primary care relies on a stepwise approach: initial risk assessment followed by interventions if indicated. Conclusion: The final set of statements represents the key characteristics of selective CMD prevention and can serve as a guide for implementing selective prevention actions in European primary care.
- MeSH
- hodnocení rizik metody MeSH
- kardiovaskulární nemoci prevence a kontrola MeSH
- konsensus MeSH
- lidé MeSH
- metabolické nemoci prevence a kontrola MeSH
- poskytování zdravotní péče organizace a řízení MeSH
- primární zdravotní péče organizace a řízení MeSH
- rizikové faktory MeSH
- služby preventivní péče organizace a řízení MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH